Last reviewed · How we verify

NCT03176329: I-Nursing

Closed-loop Versus Conventional Ventilation Mode During Mobilization Period in Critical Care Patients

Completed NA Last updated 15 August 2018
What this trial tests

NA trial testing Nursing 1 : INTELLIVENT-ASV in Critical Ill Patients in 267 participants. Completed in 31 July 2018.

Timeline
19 September 2016
Primary endpoint
31 July 2018
31 July 2018

Quick facts

Lead sponsorHopital of Melun
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposesupportive care
Enrollment267
Start date19 September 2016
Primary completion31 July 2018
Estimated completion31 July 2018
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Hopital of Melun

Who can join

18 and older, any sex, with Critical Ill Patients or Ventilated Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nursing is essential in critically ill patients care but with high risk of hypoxia, especially during mobilization. Full closed-loop control ventilation is well established for her safety in unselected ventilated critical care patients with different lung conditions compared to conventional ventilation. The aim of this study is to assess the ability of a full closed-loop control ventilation (Intellivent-ASV, TM) to reduce hypoxia during mobilization period in unselected ventilated patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Automated vs. conventional ventilation in the ICU: a randomized controlled crossover trial comparing blood oxygen saturation during daily nursing procedures (I-NURSING).
    Chelly J, Mazerand S, Jochmans S, Weyer CM, et al · · 2020 · cited 11× · PMID 32698860 · DOI 10.1186/s13054-020-03155-3

Verify or expand the search:

Other recruiting trials for Critical Ill Patients

Currently open trials in the same condition.

Other Hopital of Melun trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03176329.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing